These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 31838177)

  • 1. Resveratrol alleviates non-alcoholic fatty liver disease through epigenetic modification of the Nrf2 signaling pathway.
    Hosseini H; Teimouri M; Shabani M; Koushki M; Babaei Khorzoughi R; Namvarjah F; Izadi P; Meshkani R
    Int J Biochem Cell Biol; 2020 Feb; 119():105667. PubMed ID: 31838177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibiting miR-27a and miR-142-5p attenuate nonalcoholic fatty liver disease by regulating Nrf2 signaling pathway.
    Teimouri M; Hosseini H; Shabani M; Koushki M; Noorbakhsh F; Meshkani R
    IUBMB Life; 2020 Mar; 72(3):361-372. PubMed ID: 31889412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gentiopicroside Ameliorates Oxidative Stress and Lipid Accumulation through Nuclear Factor Erythroid 2-Related Factor 2 Activation.
    Jin M; Feng H; Wang Y; Yan S; Shen B; Li Z; Qin H; Wang Q; Li J; Liu G
    Oxid Med Cell Longev; 2020; 2020():2940746. PubMed ID: 32655764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitis.
    Lee DH; Han DH; Nam KT; Park JS; Kim SH; Lee M; Kim G; Min BS; Cha BS; Lee YS; Sung SH; Jeong H; Ji HW; Lee MJ; Lee JS; Lee HY; Chun Y; Kim J; Komatsu M; Lee YH; Bae SH
    Free Radic Biol Med; 2016 Oct; 99():520-532. PubMed ID: 27634173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chicoric Acid Ameliorates Nonalcoholic Fatty Liver Disease via the AMPK/Nrf2/NF
    Ding X; Jian T; Li J; Lv H; Tong B; Li J; Meng X; Ren B; Chen J
    Oxid Med Cell Longev; 2020; 2020():9734560. PubMed ID: 33204402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel compound AB38b attenuates oxidative stress and ECM protein accumulation in kidneys of diabetic mice through modulation of Keap1/Nrf2 signaling.
    Du L; Wang L; Wang B; Wang J; Hao M; Chen YB; Li XZ; Li Y; Jiang YF; Li CC; Yang H; Gu XK; Yin XX; Lu Q
    Acta Pharmacol Sin; 2020 Mar; 41(3):358-372. PubMed ID: 31645661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased autophagosome biogenesis, reduced NRF2, and enhanced ferroptotic cell death are underlying molecular mechanisms of non-alcoholic fatty liver disease.
    Liu P; Anandhan A; Chen J; Shakya A; Dodson M; Ooi A; Chapman E; White E; Garcia JG; Zhang DD
    Redox Biol; 2023 Feb; 59():102570. PubMed ID: 36495698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SGL 121 Attenuates Nonalcoholic Fatty Liver Disease through Adjusting Lipid Metabolism Through AMPK Signaling Pathway.
    Kim DE; Chang BY; Jeon BM; Baek JI; Kim SC; Kim SY
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (S)YS-51, a novel isoquinoline alkaloid, attenuates obesity-associated non-alcoholic fatty liver disease in mice by suppressing lipogenesis, inflammation and coagulation.
    Park EJ; Kim YM; Kim HJ; Jang SY; Oh MH; Lee DH; Chang KC
    Eur J Pharmacol; 2016 Oct; 788():200-209. PubMed ID: 27343380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scutellarin ameliorates nonalcoholic fatty liver disease through the PPARγ/PGC-1α-Nrf2 pathway.
    Zhang X; Ji R; Sun H; Peng J; Ma X; Wang C; Fu Y; Bao L; Jin Y
    Free Radic Res; 2018 Feb; 52(2):198-211. PubMed ID: 29400110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dehydroabietic acid improves nonalcoholic fatty liver disease through activating the Keap1/Nrf2-ARE signaling pathway to reduce ferroptosis.
    Gao G; Xie Z; Li EW; Yuan Y; Fu Y; Wang P; Zhang X; Qiao Y; Xu J; Hölscher C; Wang H; Zhang Z
    J Nat Med; 2021 Jun; 75(3):540-552. PubMed ID: 33590347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aescin can alleviate NAFLD through Keap1-Nrf2 by activating antioxidant and autophagy.
    Yu H; Yan S; Jin M; Wei Y; Zhao L; Cheng J; Ding L; Feng H
    Phytomedicine; 2023 May; 113():154746. PubMed ID: 36905866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Punicalagin attenuates palmitate-induced lipotoxicity in HepG2 cells by activating the Keap1-Nrf2 antioxidant defense system.
    Yan C; Sun W; Wang X; Long J; Liu X; Feng Z; Liu J
    Mol Nutr Food Res; 2016 May; 60(5):1139-49. PubMed ID: 26989875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asperuloside activates hepatic NRF2 signaling to stimulate mitochondrial metabolism and restore lipid homeostasis in high fat diet-induced MAFLD.
    He C; Zhang Q; Zhu R; Tse G; Wong WT
    Eur J Pharmacol; 2024 Nov; 983():177003. PubMed ID: 39278309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrogen Sulfide Alleviates Liver Injury Through the S-Sulfhydrated-Kelch-Like ECH-Associated Protein 1/Nuclear Erythroid 2-Related Factor 2/Low-Density Lipoprotein Receptor-Related Protein 1 Pathway.
    Zhao S; Song T; Gu Y; Zhang Y; Cao S; Miao Q; Zhang X; Chen H; Gao Y; Zhang L; Han Y; Wang H; Pu J; Xie L; Ji Y
    Hepatology; 2021 Jan; 73(1):282-302. PubMed ID: 32219872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Niga-ichigoside F1 ameliorates high-fat diet-induced hepatic steatosis in male mice by Nrf2 activation.
    Xia SF; Shao J; Zhao SY; Qiu YY; Teng LP; Huang W; Wang SS; Cheng XR; Jiang YY
    Food Funct; 2018 Feb; 9(2):906-916. PubMed ID: 29309075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic Lipid Accumulation and Nrf2 Expression following Perinatal and Peripubertal Exposure to Bisphenol A in a Mouse Model of Nonalcoholic Liver Disease.
    Shimpi PC; More VR; Paranjpe M; Donepudi AC; Goodrich JM; Dolinoy DC; Rubin B; Slitt AL
    Environ Health Perspect; 2017 Aug; 125(8):087005. PubMed ID: 28796629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocyte-specific NRF2 activation controls fibrogenesis and carcinogenesis in steatohepatitis.
    Mohs A; Otto T; Schneider KM; Peltzer M; Boekschoten M; Holland CH; Hudert CA; Kalveram L; Wiegand S; Saez-Rodriguez J; Longerich T; Hengstler JG; Trautwein C
    J Hepatol; 2021 Mar; 74(3):638-648. PubMed ID: 33342543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PSA controls hepatic lipid metabolism by regulating the NRF2 signaling pathway.
    Huang B; Xiong X; Zhang L; Liu X; Wang Y; Gong X; Sang Q; Lu Y; Qu H; Zheng H; Zheng Y
    J Mol Cell Biol; 2021 Oct; 13(7):527-539. PubMed ID: 34048566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study on the attenuated effect of Ginkgolide B on ferroptosis in high fat diet induced nonalcoholic fatty liver disease.
    Yang Y; Chen J; Gao Q; Shan X; Wang J; Lv Z
    Toxicology; 2020 Dec; 445():152599. PubMed ID: 32976958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.